US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

HCG Reconstitued 6000 IU Injectable

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1739-06 D-0158-2019
Class II · Moderate risk Terminated

HCG Reconstitued 50

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1736-50 D-0157-2019
Class II · Moderate risk Terminated

Glycerin 72%

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1401-30 D-0155-2019
Class II · Moderate risk Terminated

Glutathione 200 mg/mL Solution

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1504-30 D-0154-2019
Class II · Moderate risk Terminated

Glutamine 10 mg/mL Solution

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1439-59 D-0153-2019
Class II · Moderate risk Terminated

Dexpanthenol Injection

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1610-30 D-0150-2019
Class II · Moderate risk Terminated

Calcium Gluconate 10%

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-0914-30 D-0148-2019
Class II · Moderate risk Terminated

Bi-Mix

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1760-15 D-0144-2019
Class II · Moderate risk Terminated

Bi-Mix Injection

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1317-03 D-0143-2019
Class II · Moderate risk Terminated

Bi-Mix Injection

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1305-03 D-0142-2019
Class II · Moderate risk Terminated

Bi-Mix Injection

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1323-05 D-0141-2019
Class II · Moderate risk Terminated

Beta-complex B-1

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1611-30 D-0139-2019
Class II · Moderate risk Terminated

Arginine Injections 100 mcg/mL

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1414-20 D-0137-2019
Class II · Moderate risk Terminated

Acetylcysteine Injection 10 mg/5 mL

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1424-10 D-0136-2019
Class II · Moderate risk Terminated

Actoplus met XR

Reason Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

Takeda Development Center Americas, Inc. D-0026-2019
Class II · Moderate risk Terminated

Minivelle

Reason Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Noven Pharmaceuticals, Inc. NDC 68968-6675-8 D-1210-2018